1. Home
  2. CNTX
  3. CNTX News

Latest Context Therapeutics Inc. (CNTX) News on January 22, 2025

Context doses first subject in Phase I cancer trial of CTIM-76

Clinical Trials Arena

7 days ago

Context doses first subject in Phase I cancer trial of CTIM-76

Share on Social Networks: